TUNITAS THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects
Phase 1
Terminated
- Conditions
- Allergy and Immunology
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- Tunitas Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT02559258
- Locations
- 🇦🇺
Q-Pharm, Brisbane, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath